1. Introduction {#sec1-ijerph-15-01519}
===============

In 2014, the World Health Organization reported that there are an estimated 1.9 billion adults who were overweight, with approximately 600 million deemed to be obese (with a body mass index of more than 30) \[[@B1-ijerph-15-01519]\]. These figures highlight that obesity is clearly a problem that afflicts a global population. The increasing rates of obesity globally can be attributed mainly to changing dietary norms, as well as decreasing levels of physical activity among individuals \[[@B1-ijerph-15-01519]\]. Obesity heightens the risk of an individual developing medical comorbidities, such as diabetes, cardiovascular diseases and some forms of carcinomas \[[@B2-ijerph-15-01519]\]. Apart from the association between obesity and medical disorders, prior research has highlighted an association between obesity and psychiatric disorders \[[@B3-ijerph-15-01519]\]. In the aforementioned review \[[@B3-ijerph-15-01519]\], there was evidence of a bi-directional association of obesity and depressive disorders and females, in particular, tend to be at risk. An association between obesity and anxiety disorders was also found, and alcohol abuse appears to be a predisposing factor towards the development of obesity \[[@B3-ijerph-15-01519]\].

Various strategies have been implemented in order to tackle the growing problem of obesity. Such strategies include educational and dietary programs \[[@B4-ijerph-15-01519]\]. While these programs are largely efficacious, there are individuals who remains severely obese, despite their participation in these programs. Various clinical guidelines recommend bariatric surgery as an option for individuals who have recalcitrant obesity, that is, refractory to non-operative management \[[@B5-ijerph-15-01519],[@B6-ijerph-15-01519]\]. Bariatric surgery has been widely utilized, with approximately 468,809 procedures done in 2013 \[[@B7-ijerph-15-01519]\], and has been effective in the management of obesity. There is a variety of operative procedures that can be performed, and the amount of weight loss is dependent on the procedure utilized. Aside from the main benefits of weight loss, individuals who have undergone bariatric surgery may also gain optimal control of their diabetic and hypertensive disorders and resolution of obstructive sleep apnoea \[[@B8-ijerph-15-01519],[@B9-ijerph-15-01519],[@B10-ijerph-15-01519]\].

While bariatric surgery seems to be a solution to obesity as well as the associated medical comorbidities, prior studies have highlighted that there remains an elevated risk of suicide among patients who have undergone bariatric surgery \[[@B11-ijerph-15-01519]\]. A prior meta-analysis reported that the suicide rate was 4.1/10,000 person-years among post-operative bariatric patients, and this was four times higher as compared to the general population \[[@B12-ijerph-15-01519]\]. Other studies (Tindle et al.) \[[@B13-ijerph-15-01519]\] have reported rates of suicide as high as 6.6/10,000 patients. Obesity is associated with a variety of psychiatric and affective disorders, for example, depressive disorders are commonly associated with obesity. A recent study of 10,000 bariatric patients in Canada reported that 41.7% of patients had depression and 2.2% had bipolar disorder pre-operatively \[[@B14-ijerph-15-01519]\]. There have been studies reporting that the risk of post-operative suicide remains high \[[@B15-ijerph-15-01519]\]. A prior study reported that self-esteem might account for the relationship between obesity and suicidality \[[@B16-ijerph-15-01519]\]. Self-esteem affect one's viewpoint of one's body image and individuals with low self-esteem might have a poorer perception of their body image, which leads to the development of depression \[[@B16-ijerph-15-01519]\]. In addition, some of the chronic medical comorbidities may persist despite bariatric surgery and the presence of these medical issues might cause an individual to have a sense of failure and disappointment \[[@B17-ijerph-15-01519]\]. It is also important to recognize that the risk of suicide is increased among individuals with disorders such as diabetes. Bariatric surgery can also result in physiological changes, and this may affect the metabolism of substances like alcohol, which might be implicated in suicide attempts. Changes in the levels of peripheral released peptides might also affect mood. Patients with pre-existing emotional eating disorders might still have maladaptive patterns of eating post-operatively that lead to weight gain and result in a sense of disappointment.

Previous studies have reported short-term as well as long-term all-cause mortality (Cardoso et al., 2017) \[[@B11-ijerph-15-01519]\]. The estimated prevalence of short-term mortality was 0.18% and it was also reported that operated patients were less likely to succumb to cardiovascular disorders and carcinomas in the longer-term. Whilst the meta-analysis performed by Cardoso et al. (2017) \[[@B11-ijerph-15-01519]\] appears to be comprehensive and timely, one of the major limitations is that the authors have not considered mortality due to suicide in their review. Also, the prior study \[[@B12-ijerph-15-01519]\] examining the prevalence of completed suicide was done more than 4 years ago. Hence, a current meta-analysis is of importance in providing an updated pooled prevalence rate for suicide, and for comparing it against that of all-cause mortality in the same cohort.

Thus, this meta-analysis aims to determine the pooled prevalence of mortality and suicide among the cohort of bariatric surgery patients with reported suicides. It is also the aim of the meta-analysis to determine the moderators that account for the heterogeneity of the pooled prevalence obtained.

2. Methodology {#sec2-ijerph-15-01519}
==============

2.1. Comprehensive Search Strategy {#sec2dot1-ijerph-15-01519}
----------------------------------

A comprehensive search was undertaken between 1 January 2017 and 28 February 2017. Entire databases were searched from inception with the following databases being evaluated: PubMed (since 1966), Embase (since 1980), PsychINFO (since 1806), BIOSIS (since 1926), Science Direct (since 2006), and Cochrane CENTRAL (since 1993).

The keywords used in the search strategy include; (obesity surgery, bariatric surgery, gastric bypass, biliopancreatic diversion, endoluminal sleeve, vertical banded gastroplasty, gastric band, sleeve gastrectomy, gastric balloon, gastric plication, duodenal switch, implantable gastric stimulation) AND (suicide OR mortality).

2.2. Inclusion and Exclusion Criteria {#sec2dot2-ijerph-15-01519}
-------------------------------------

The inclusion criteria for the meta-analysis were as follows: (1) papers which provided numbers of suicide in the cohort, and (2) papers with recipients of bariatric surgery form the study population.

The exclusion criteria for the meta-analysis were as follows: (1) non-English language papers, and (2) papers with unclear/unknown causes of death listed.

2.3. Selection of Articles {#sec2dot3-ijerph-15-01519}
--------------------------

All the titles, authors' information, as well as the journal and year of publication were removed prior to the selection procedure. Selection of the relevant publications were conducted independently by of the first two authors (RBCL & MWBZ) of this paper. In the first phase, articles were screened based on their titles as well as abstract. Those articles which were shortlisted were then evaluated against the aforementioned inclusion and exclusion criteria. In the event of any disagreement amongst the two authors, it was resolved by means of a discussion with the author, RCMH. The selection procedure was in accordance to PRISMA guidelines.

2.4. Statistical Methods {#sec2dot4-ijerph-15-01519}
------------------------

### 2.4.1. Data Extraction {#sec2dot4dot1-ijerph-15-01519}

The following information was extracted from each of the article, cross-checked by the second author as well as the last author and recorded on a standardized electronic data collation form: (a) publication details (names of the authors and year of publication); (b) the total number of deaths as well as the number of suicides; (c) the total sample size of each of the studies; (d) the mean age of the participants; (e) the proportion of males and females in the population surveyed; (f) the mean BMI of the participants; (g) the operative procedure utilized; (h) the country in which the participant were sampled from, and lastly, (i) the total duration of the follow-up.

### 2.4.2. Statistical Analysis {#sec2dot4dot2-ijerph-15-01519}

All statistical analyses were performed using comprehensive meta-analysis. This meta-analysis used a random-effects model that assumed heterogeneity between studies and their respective effect sizes (Ho et al. 2010, Cheung et al. 2012) \[[@B18-ijerph-15-01519],[@B19-ijerph-15-01519]\]. We used standardized mean difference to establish the overall effect size in each of the studies and presented our findings in the forest plots. We reported the results using 95% confidence interval (CI). Between-study heterogeneity was assessed with the I^2^ statistic (Loh et al. 2017) \[[@B20-ijerph-15-01519]\]. As a guide, I^2^ values of 25% were considered low, 50% moderate, and 75% high (Ho et al. 2016) \[[@B21-ijerph-15-01519]\]. For models with considerable heterogeneity, a meta-regression was performed to identify the moderators which might contribute to the heterogeneity of the effect sizes (Lu et al. 2012) \[[@B22-ijerph-15-01519]\]. The regression coefficients and the associated z values and p values were reported in the meta-regression analysis. In the event that publication bias was detected, the classic fail-safe test was performed to establish the potential number of missing studies (Puthran et al. 2016) \[[@B23-ijerph-15-01519]\]. Egger's regression test was also conducted to determine if publication bias was present.

Two separate subgroup analyses were undertaken to investigate the effects of categorical variables on the pooled prevalence of mortality amongst cohort with reported suicide and on the pooled prevalence of suicide itself. We compared the prevalence of suicide among the following subgroups: (a) operative procedure that was utilized and (b) continent in which the study was conducted.

3. Results {#sec3-ijerph-15-01519}
==========

A cumulative total of 7614 published abstract were screened and 390 full text articles were reviewed and were selected based on our inclusion criteria. Sixty-one studies with a pooled cohort size of 142,356 were included in this systematic review and meta-analysis ([Figure 1](#ijerph-15-01519-f001){ref-type="fig"}). Characteristics of the studies included are described in [Table 1](#ijerph-15-01519-t001){ref-type="table"}. There was a total of 43 prospective cohort studies, 14 retrospective cohort studies, one randomized controlled study and three case control studies. The studies which we identified have reported all-cause mortality and mortality due to suicide.

Overall, the pooled prevalence of mortality in these studies which reported suicidal mortality was 1.8% (95% confidence interval 1.4--2.4%, Z = −29.228, df = 60, τ^2^ = 0.933, I^2^ = 95.779). This meta-analysis revealed significant heterogeneity across studies (*p* \< 0.001). The pooled prevalence of suicide was 0.3% (95% confidence interval 0.3--0.4%, Z = −39.133, df = 60, τ^2^ = 0.684, I^2^ = 66.202).

We also tested for publication bias using the Egger regression test. Publication bias was not evident in the meta-analysis of all the studies (intercept = −0.98486, 95% CI: −2.79555--0.82584, t = 1.08836, df = 59, *p* = 0.28086).

In the meta-regression analyses ([Table 2](#ijerph-15-01519-t002){ref-type="table"}), certain variables were found to be significantly associated with the overall pooled mortality prevalence. We found that the mean BMI (β = 0.008282, Z = 2.37980, *p* = 0.01732) and the follow-up interval (β = 0.01177, Z = 4.34545, *p* = 0.00001) were significant moderators for the pooled mortality prevalence. The mean age of the sampled cohort as well as the proportion of males in the sampled cohort were not found to be moderators.

Subgroup analysis of the prevalence rates based on the random effects model for the categorical variables (the types of bariatric surgical procedure as well as the continent where the cohort was sampled) found that these variables were not moderators for the overall prevalence of mortality among bariatric cohorts with reported suicide mortality ([Table 3](#ijerph-15-01519-t003){ref-type="table"}).

A further subgroup analysis was performed for the prevalence rates of suicide based on the random effects model for categorical variables (the types of bariatric surgical procedure as well as the continent where the cohort was sampled) and found that these variables were not moderators for the overall prevalence of mortality among bariatric patients ([Table 4](#ijerph-15-01519-t004){ref-type="table"}).

4. Discussion {#sec4-ijerph-15-01519}
=============

The current meta-analysis is, to our knowledge, the most up-to-date meta-analysis to examine the pooled prevalence of all-cause mortality as well as suicide in bariatric surgery cohorts with reported suicides. In our current study, the pooled prevalence of all-cause mortality was 1.8% across a total of 61 studies with a pooled cohort size of 142,356. The pooled prevalence of suicide was 0.3%. Notably, our computed pooled prevalence rates were much higher than those reported by prior studies, such as that of Cardoso et al. (2017) \[[@B11-ijerph-15-01519]\], in which it was reported that the short-term all-cause mortality rate was 0.18%; and that of Chang et al. \[[@B84-ijerph-15-01519]\], that reported a mortality rate of 0.08%. Based on our computation, the rate of all-cause mortality is approximately 6 times higher than that for suicide. This implies that some bariatric patients do experience other complications that might result in morbidity and eventual mortality. Rottensterich et al. (2016) \[[@B85-ijerph-15-01519]\] has reported that whilst bariatric surgery helps in the weight loss amongst individuals with Type 1 diabetes, some individuals experience post-operative complications such as diabetic ketoacidosis and hypoglycaemic episodes. Prior studies have reported that factors such as gender, age, high baseline body mass index, the presence of pre-existing diabetes, history of percutaneous coronary intervention, a history of peripheral vascular disease and a need for reoperation heighten the chances of post-operative mortality \[[@B86-ijerph-15-01519]\].

The pooled prevalence of suicide after bariatric surgery was 0.3%. This is a notable finding, given that most of the recent meta-analysis and systematic reviews have not reported on mortality due to psychiatric conditions. The most recent review that has considered suicide following bariatric surgery was conducted by Peterhansel et al. (2012) \[[@B12-ijerph-15-01519]\], who reported that the suicide rate was estimated to be that of 4.1/10,000 person-years. To put these rates into perspective, the prevalence of suicide globally is 1.4%, based on an epidemiological study by the World Health Organization \[[@B87-ijerph-15-01519]\]. Despite the fact that the pooled prevalence of suicide is 6 times lower than that of all-cause mortality, and that the rates are also comparatively lower as compared to the rates among the general population (1.4%), there is still a need for a comprehensive evaluation of the psychiatric well-being of individuals both pre and post-operatively. Prior studies have highlighted the association between bariatric surgery and suicide (Adam et al., 2015) \[[@B88-ijerph-15-01519]\]. Roziblatt et al. (2016) \[[@B89-ijerph-15-01519]\] suggested that individuals who have pre-existing psychiatric conditions such as depression and eating disorders, are more likely to be at risk for suicide post-surgery. Thus, given this heightened risk, Roziblatt et al. (2016) \[[@B89-ijerph-15-01519]\] recommended the need for a psychiatrist to follow up with the patient prior to and after their slated surgery. Yen et al. (2016) \[[@B15-ijerph-15-01519]\] reported that 40% of bariatric patients have underlying psychiatric disorders and stressed that it is of importance for early identification and optimization of these conditions, as they in turn affect the outcome of the surgery. Yen et al. (2016) \[[@B15-ijerph-15-01519]\] also recommended various non-pharmacological options such as psychotherapy to help individuals with their depressive symptoms post-surgery. Based on the characteristics of the study presented in [Table 1](#ijerph-15-01519-t001){ref-type="table"}, there has been a general increase in the number of suicides following bariatric surgery, with clusters of cases being more frequently reported in 2007 and 2010, and especially so in 2010, where a single study (Tindle et al., 2010) \[[@B13-ijerph-15-01519]\] reported a total of 31 suicides. More recently, in 2015--2017, there was an increase in the number of suicides as well, with a single study reporting 17 suicides (Laggeros et al., 2017) \[[@B46-ijerph-15-01519]\]. Given the risk of suicide associated with bariatric surgery and the incidence of psychiatric disorders among individuals undergoing bariatric surgery, it is important to have a multi-disciplinary team caring for these individuals. Based on the best practice guidelines, it is of importance to have a psychiatrist, psychologist and social worker as part of the psychosocial care team \[[@B90-ijerph-15-01519]\] and it is also essential for these healthcare professionals to have prior experience with working with such patients. Some of the commonly used questionnaires used for psychiatric assessment include the Beck-Depression Inventory, the Symptom Checklist-90-Revised (SCL-90-R), the Eating Disorder Inventory-2, Beck Anxiety Inventory and the Eating Disorders Examination (EDE-Q). Psychological interventions, in particular cognitive behavioral therapy, have been most widely used in the treatment, and patients routinely attend up to twelve sessions.

Our current study also identified the mean body mass index (BMI) as well as the duration of follow-up to be significant moderators of the heterogeneity found in the pooled prevalence for mortality. The fact that body mass index (BMI) mediates the heterogeneity of the pooled prevalence is not surprising given that a previous study by Padwal et al. (2013) \[[@B91-ijerph-15-01519]\] tried to determine the importance of BMI as a mortality predictor. Padwal et al. (2013) \[[@B91-ijerph-15-01519]\] found that BMI did have an effect on the absolute rate of mortality and in their study, the odds ratio computed was 1.03. In the current meta-analytic study, the duration of follow-up was found to be a significant moderator and we hypothesize that a longer-term follow-up would affect the mortality measures, given that there are short-term and longer-term causes that could lead to mortality (Cardoso et al., 2017) \[[@B11-ijerph-15-01519]\].

There are several strengths of this current review. We comprehensively searched through the literature and looked at all studies that have reported mortality as well as suicide, and we have included studies that reported both statistics, in order to compare the overall pooled prevalence rates. Meta-analytical regression analysis as well as subgroup analysis were performed. However, the current study has several inherent limitations. These include 50 non-English language papers and 58 studies with unclear or unknown causes of mortality listed that were excluded for ease of analysis. In addition, suicide data amongst the analysed papers is also sparse, with data about the demographics, reasons, and time from surgery being generally available. Also, most studies failed to report how they managed to obtain information about deaths (such as whether they screened death records, etc.). Additionally, deaths from alcoholic cirrhosis, drug overdoses, poisonings, and accidents not explicitly stated as suicide were excluded from analysis. Most papers analysed also listed low rates of long-term follow-up. Subgroup analysis was performed using the longest follow-up period recorded as most studies did not state clear default rates and average follow-up duration for extraction. It is possible that suicide and mortality occur amongst subjects lost to follow-up, which may further increase the pooled prevalence of suicide and mortality as compared to the given results.

5. Conclusions {#sec5-ijerph-15-01519}
==============

The current study computed the pooled prevalence of all-cause mortality as well as that of suicide among cohorts with reported suicide following bariatric surgery. The findings from the current meta-analysis have resultant clinical implications. There is a need for a multi-disciplinary team to look into the psychological well-being of bariatric patients pre and postoperatively.
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###### 

Characteristics of the included studies.

       Author and Year                                          Study Type                    Sample Size (n)   Mortality (n)   Suicide (n)   Mean Age   \% Male   \% Female   Mean BMI   Procedure                                                                                                                                                       Country           Longest Follow-Up (Month)
  ---- -------------------------------------------------------- ----------------------------- ----------------- --------------- ------------- ---------- --------- ----------- ---------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------- ---------------------------
  1    Aarts et al. 2014 \[[@B24-ijerph-15-01519]\]             Prospective Cohort Study      201               6               1             37         0.23      0.77        45.6       Laparoscopic adjustable gastric banding                                                                                                                         The Netherlands   216
  2    Adams et al. 2007 \[[@B25-ijerph-15-01519]\]             Retrospective Cohort Study    9949              288             21            39.3       0.14      0.86        44.9       Roux- En-Y Gastric Bypass                                                                                                                                       USA               216
  3    Adams et al. 2012 \[[@B26-ijerph-15-01519]\]             Prospective Cohort Study      1156              12              4             42.5       0.18      0.82        45.9       Roux- En-Y Gastric Bypass                                                                                                                                       USA               72
  4    Arapis et al. 2017 \[[@B27-ijerph-15-01519]\]            Prospective Cohort Study      897               6               1             39.5       0.13      0.87        39.5       Laproscopic adjustable gastric banding                                                                                                                          France            228
  5    Arman et al. 2016 \[[@B28-ijerph-15-01519]\]             Prospective Cohort Study      106               2               1             38.5       0.26      0.74        38.5       Laproscopic Sleeve Gastrectomy                                                                                                                                  Belgium           140
  6    Biertho et al. 2010 \[[@B29-ijerph-15-01519]\]           Retrospective Cohort Study    810               25              5             41.1       0.21      0.79        44.2       Biliopancreatic diversion with duodenal switch                                                                                                                  Canada            201
  7    Bolckmans et al. 2016 \[[@B30-ijerph-15-01519]\]         Retrospective Cohort Study    153               9               1             40.6       0.16      0.84        46.4       Biliopancreatic diversion with duodenal switch                                                                                                                  Belgium           135
  8    Busetto et al. 2007 \[[@B31-ijerph-15-01519]\]           Case control study            821               8               1             38.2       0.24      0.76        48.6       Laproscopic adjustable gastric banding                                                                                                                          Italy             120
  9    Busetto et al. 2014 \[[@B32-ijerph-15-01519]\]           Prospective Cohort Study      318               15              1             38.6       0.18      0.82        46.7       Laproscopic adjustable gastric banding                                                                                                                          Italy             120
  10   Cadiere et al. 2011 \[[@B33-ijerph-15-01519]\]           Retrospective Cohort Study    470               1               1             40         0.166     0.834       NA         Laproscopic gastric bypass                                                                                                                                      Belgium           66
  11   Capella et al. 1996 \[[@B34-ijerph-15-01519]\]           Prospective Cohort Study      888               8               3             37         0.178     0.822       52         Vertical banded gastroplasty/Vertical banded gastroplasty-Roux-en-y gastric bypass                                                                              USA               60
  12   Carelli et al. 2010 \[[@B35-ijerph-15-01519]\]           Retrospective Cohort Study    2909              10              1             NA         0.32      0.68        45.27      Laproscopic adjustable gastric banding                                                                                                                          USA               60
  13   Christou et al. 2006 \[[@B36-ijerph-15-01519]\]          Retrospective Cohort Study    272               8               2             42         0.18      0.82        48.1       Roux- En-Y Gastric Bypass                                                                                                                                       Canada            NA
  14   Cobourn et al. 2013 \[[@B37-ijerph-15-01519]\]           Retrospective Cohort Study    2815              9               1             43         0.18      0.82        44.6       Laproscopic Adjustable Gastric Banding                                                                                                                          Canada            60
  15   Diniz et al. 2013 \[[@B38-ijerph-15-01519]\]             Prospective Cohort Study      248               9               2             39.7       0.25      0.75        53         Roux- En-Y Gastric Bypass                                                                                                                                       Brazil            NA
  16   Goldfeder et al. 2006 \[[@B39-ijerph-15-01519]\]         Retrospective Cohort Study    107               107             1             NA         NA        NA          NA         NA                                                                                                                                                              USA               NA
  17   Girbsholt et al. 2016 \[[@B40-ijerph-15-01519]\]         Retrospective Cohort Study    9895              91              10            40.2       0.217     0.783       46         Roux- En-Y Gastric Bypass                                                                                                                                       Denmark           50
  18   Higa et al. 2000 \[[@B41-ijerph-15-01519]\]              Prospective Cohort Study      1040              5               1             NA         0.174     0.826       47.8       Roux- En-Y Gastric Bypass                                                                                                                                       USA               12
  19   Himpens et al. 2011 \[[@B42-ijerph-15-01519]\]           Prospective Cohort Study      82                3               1             50         0.1       0.9         41.57      Laproscopic Adjustable Gastric Banding                                                                                                                          Belgium           NA
  20   Himpens et al. 2012 \[[@B43-ijerph-15-01519]\]           Prospective Cohort Study      77                2               1             38.9       0.2       0.8         40.3       Laproscopic Roux-En-Y Gastric bypass                                                                                                                            Belgium           112
  21   Kelles et al. 2014 \[[@B44-ijerph-15-01519]\]            Prospective Cohort Study      4344              82              8             34.9       0.21      0.79        42         Roux- En-Y Gastric Bypass                                                                                                                                       Brazil            120
  22   Kral et al. 1993 \[[@B45-ijerph-15-01519]\]              Prospective Cohort Study      69                3               1             38         0.18      0.82        47         Vertical Banded Gastroplasty                                                                                                                                    Sweden            60
  23   Laggeros et al. 2017 \[[@B46-ijerph-15-01519]\]          Retrospective Cohort Study    22,539            NA              17            41.3       0.753     0.247       NA         NA                                                                                                                                                              Sweden            26
  24   Lemanu et al. 2015 \[[@B47-ijerph-15-01519]\]            Prospective Cohort Study      96                3               1             46.9       0.182     0.818       50.7       Laproscopic Sleeve Gastrectomy                                                                                                                                  New Zealand       60
  25   Macdonald et al. 1997 \[[@B48-ijerph-15-01519]\]         Prospective Cohort Study      154               14              1             41.9       0.234     0.766       50.6       Roux- En-Y Gastric Bypass                                                                                                                                       USA               132
  26   Maclean et al. 2000 \[[@B49-ijerph-15-01519]\]           Prospective Cohort Study      274               3               1             NA         NA        NA          43.2       Isolated Gastric Bypass                                                                                                                                         Canada            NA
  27   Marceau et al. 2007 \[[@B50-ijerph-15-01519]\]           Prospective Cohort Study      1423              67              6             40.1       NA        NA          51.5       Duodenal Switch                                                                                                                                                 Canada            180
  28   Marceau et al. 2009 \[[@B51-ijerph-15-01519]\]           Prospective Cohort Study      686               49              3             NA         NA        NA          48.3       Biliopancreatic diversion with distal gastrectomy/Biliopancreatic diversion with duodenal switch                                                                Canada            120
  29   Marceau et al. 2015 \[[@B52-ijerph-15-01519]\]           Prospective Cohort Study      2615              123             9             42         0.307     0.693       52         Biliopancreatic diversion                                                                                                                                       Canada            NA
  30   Marsk et al. 2010 \[[@B53-ijerph-15-01519]\]             Case control study            1216              43              4             NA         1         0           NA         NA                                                                                                                                                              Sweden            NA
  31   Mcphee et al. 2015 \[[@B54-ijerph-15-01519]\]            Case control study            206               2               2             NA         NA        NA          NA         Laproscopic sleeve gastrectomy/Laproscopic adjustable gastric banding                                                                                           USA               NA
  32   Mitchell et al. 2001 \[[@B55-ijerph-15-01519]\]          Prospective Cohort Study      78                8               1             56.8       0.17      0.83        43.8       Gastric bypass                                                                                                                                                  USA               180
  33   Naslund et al. 1994 \[[@B56-ijerph-15-01519]\]           Prospective Cohort Study      37                5               2             37         0.18      0.82        45.5       Gastric banding                                                                                                                                                 Sweden            120
  34   Naslund et al. 1995 \[[@B57-ijerph-15-01519]\]           Prospective Cohort Study      158               3               1             39.3       0.16      0.84        44.7       Vertical Banded Gastroplasty                                                                                                                                    Sweden            NA
  35   Nocca et al. 2007 \[[@B58-ijerph-15-01519]\]             Prospective Cohort Study      163               1               1             41         0.32      0.68        45.9       Laproscopic Sleeve Gastrectomy                                                                                                                                  France            24
  36   N Obeid et al. 2015 \[[@B59-ijerph-15-01519]\]           Prospective Cohort Study      328               9               2             41.4       0.17      0.83        47.5       Roux- En-Y Gastric Bypass                                                                                                                                       USA               120
  37   O'Brien et al. 2013 \[[@B60-ijerph-15-01519]\]           Prospective Cohort Study      3227              4               1             47.1       0.22      0.78        43.8       Laproscopic Adjustable Gastric Banding                                                                                                                          Australia         120
  38   Omalu et al. 2007 \[[@B61-ijerph-15-01519]\]             Retrospective Cohort Study    16,683            440             16            48         0.177     0.823       NA         NA                                                                                                                                                              USA               NA
  39   Peeters et al. 2007 \[[@B62-ijerph-15-01519]\]           Cohort study                  966               4               1             47         0.23      0.77        44.9       Laproscopic Adjustable Gastric Banding                                                                                                                          Australia         NA
  40   Pekkarinen et al. 1994 \[[@B63-ijerph-15-01519]\]        Prospective Cohort Study      33                3               1             36         0.33      0.67        50         Vertical Banded Gastroplasty                                                                                                                                    Finland           NA
  41   Pories et al. 1992 \[[@B64-ijerph-15-01519]\]            Prospective Cohort Study      515               23              3             NA         0.15      0.85        NA         Greenville Gastric Bypass                                                                                                                                       USA               132
  42   Pories et al. 1995 \[[@B65-ijerph-15-01519]\]            Prospective Cohort Study      608               34              3             37.3       0.168     0.832       NA         Greenville Gastric Bypass                                                                                                                                       USA               168
  43   Powers et al. 1992 \[[@B66-ijerph-15-01519]\]            Prospective Cohort Study      100               2               1             38.8       0.15      0.85        47         Vertical Banded Gastroplasty                                                                                                                                    USA               NA
  44   Powers et al. 1007 \[[@B67-ijerph-15-01519]\]            Prospective Cohort Study      131               5               1             39.4       0.15      0.85        NA         NA                                                                                                                                                              USA               NA
  45   Rawlins et al. 2012 \[[@B68-ijerph-15-01519]\]           Prospective Cohort Study      55                2               1             44         0.3       0.7         65         Laproscopic Sleeve Gastrectomy                                                                                                                                  USA               60
  46   Rutte et al. 2014 \[[@B69-ijerph-15-01519]\]             Prospective Cohort Study      1041              6               1             42.5       0.29      0.71        44.3       Sleeve gastrectomy                                                                                                                                              The Netherlands   60
  47   Shah et al. 2016 \[[@B70-ijerph-15-01519]\]              Prospective Cohort Study      3795              14              1             42.4       0.21      0.79        40.9       Roux- En-Y Gastric Bypass                                                                                                                                       Norway            60
  48   Sieber et al. 2013 \[[@B71-ijerph-15-01519]\]            Prospective Cohort Study      68                1               1             43.1       0.22      0.78        43         Laproscopic Sleeve Gastrectomy                                                                                                                                  Switzerland       NA
  49   Skroubis et al. 2010 \[[@B72-ijerph-15-01519]\]          Prospective Cohort Study      1162              21              2             36.3       0.26      0.74        53         Vertical Banded Gastroplasty/Laproscopic sleeve gastrectomy/Roux-en-y gastric bypass/Biliopancreatic diversion                                                  Greece            NA
  50   Smith et al. 1995 \[[@B73-ijerph-15-01519]\]             Retrospective Cohort Study    3855              24              2             NA         0.11      0.89        NA         Roux- En-Y Gastric Bypass                                                                                                                                       USA               84
  51   Smith et al. 2004 \[[@B74-ijerph-15-01519]\]             Retrospective Cohort Study    779               2               1             39.3       NA        NA          40.32      Roux- En-Y Gastric Bypass                                                                                                                                       USA               29
  52   Suter et al. 2006 \[[@B75-ijerph-15-01519]\]             Prospective Cohort Study      317               5               1             38         0.136     0.864       43.5       Laproscopic Adjustable Gastric Banding                                                                                                                          Switzerland       84
  53   Suter et al. 2011 \[[@B76-ijerph-15-01519]\]             Prospective Cohort Study      379               9               2             39.4       0.26      0.74        46.3       Roux- En-Y Gastric Bypass                                                                                                                                       Switzerland       84
  54   Svenheden et al. 1997 \[[@B77-ijerph-15-01519]\]         Prospective Cohort Study      95                2               1             NA         0.21      0.79        42.5       Vertical Banded Gastroplasty                                                                                                                                    Sweden            24
  55   Tao et al. 2014 \[[@B78-ijerph-15-01519]\]               Retrospective Cohort Study    22,487            85              1             NA         NA        NA          NA         Gastric bypass/Gastric Banding/Vertical Banded Gastroplasty/Laproscopic Sleeve Gastrectomy/Billiopancreatic Diversion with duodenal Switch/Jejunoileal bypass   Sweden            12
  56   Thereaux et al. 2014 \[[@B79-ijerph-15-01519]\]          Prospective Cohort Study      330               7               1             43.4       0.089     0.911       46.9       Laproscopic Roux-En-Y Gastric bypass                                                                                                                            France            60
  57   Tindle et al. 2010 \[[@B13-ijerph-15-01519]\]            Prospective Cohort Study      16,683            NA              31            48         0.177     0.823       NA         Various                                                                                                                                                         USA               NA
  58   Van de Weijgert et al. 1999 \[[@B80-ijerph-15-01519]\]   Prospective Cohort Study      153               10              1             34         0.131     0.869       46         Roux-en-Y Gastric Bypass/Vertical Banded Gastroplasty                                                                                                           The Netherlands   168
  59   Werling et al. 2012 \[[@B81-ijerph-15-01519]\]           Randomized Controlled Study   82                2               1             44.9       0.28      0.72        42.1       Roux-en-Y Gastric Bypass/Vertical Banded Gastroplasty                                                                                                           Sweden            120
  60   Yale 1989 \[[@B82-ijerph-15-01519]\]                     Prospective Cohort Study      537               9               5             36         0.162     0.838       46.8       Roux-en-Y GastroJejunostomy/Vertical Banded Gastroplasty/Gastrogastrotomy                                                                                       USA               60
  61   Zitsman et al. 2014 \[[@B83-ijerph-15-01519]\]           Prospective Cohort Study      137               2               1             17         0.31      0.69        48.3       Laproscopic Adjustable Gastric Banding                                                                                                                          USA               60
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###### 

Meta-regression analysis on the sources of heterogeneity for the prevalence of mortality among bariatric surgery cohorts with reported suicide mortality.

  Moderators                   No. of Studies Used   Slope      Standard Error   Lower Limit (95% CI)   Upper Limit (95% CI)   *Z* Value   *p* Value
  ---------------------------- --------------------- ---------- ---------------- ---------------------- ---------------------- ----------- ------------
  Mean Age                     50                    −0.02370   0.03244          −0.08729               0.03988                −0.73065    0.46499
  Proportion of males          54                    −0.01258   0.01069          −0.03353               0.00838                −1.17621    0.23951
  Mean BMI                     49                    0.008284   0.03481          0.01461                0.15107                2.37980     0.01732 \*
  Longest follow-up interval   44                    0.01177    0.00271          0.00646                0.01708                4.34545     0.00001 \*

\* *p* \< 0.05 is considered significant. Mean BMI and Follow-up interval are significant moderators.
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###### 

Subgroup analysis on the sources of heterogeneity for the prevalence of mortality among bariatric surgery cohorts with reported suicide mortality.

  Predictor                                     No. of Studies   Pooled Prevalence (%)   95% CI     *p*-Value in between Group Comparison
  --------------------------------------------- ---------------- ----------------------- ---------- ---------------------------------------
  Restrictive procedures                        25               1.4                     0.9--2.3   0.309
  Malabsorptive procedures                      24               2.4                     1.8--3.3   
  Restrictive and/or Malabsorptive procedures   6                1.6                     0.6--4.1   
  Unspecified procedures                        6                2.5                     0.6--9.2   
  Overall:                                      61               2.1                     1.6--2.7   
  Continent---North America                     28               2.1                     1.5--2.9   0.380
  Continent---Europe                            28               1.7                     1.1--2.7   
  Continent---South America                     2                2.4                     1.3--4.5   
  Continent---Oceania                           3                0.5                     0.1--3.1   
  Overall:                                      61               2.0                     1.6--2.5   
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###### 

Subgroup analysis on the sources of heterogeneity for the prevalence of suicide.

  Predictor                                     No. of Studies   Pooled Prevalence (%)   95% CI     *p*-Value in between Group Comparison
  --------------------------------------------- ---------------- ----------------------- ---------- ---------------------------------------
  Restrictive procedures                        25               0.5                     0.3--0.8   0.131
  Malabsorptive procedures                      24               0.3                     0.2--0.4   
  Restrictive and/or Malabsorptive procedures   6                0.3                     0.1--1.0   
  Unspecified procedures                        6                0.2                     0.1--0.3   
  Overall:                                      61               0.3                     0.2--0.4   
  Continent---North America                     28               0.3                     0.2--0.5   0.878
  Continent---Europe                            28               0.4                     0.2--0.6   
  Continent---South America                     2                0.3                     0.1--1.4   
  Continent---Oceania                           3                0.1                     0--1.1     
  Overall:                                      61               0.3                     0.3--0.5   
